-

RQM+ Appoints Denise Wocko as Head of Global Client Portfolio Management

PITTSBURGH--(BUSINESS WIRE)--RQM+, the world’s leading MedTech service provider, today announced the appointment of Denise Wocko as head of global client portfolio management. In her new role, Wocko will work directly with RQM+ clients to provide seamless access to its integrated services, including reimbursement, clinical trials, lab testing and regulatory consulting, that support all phases of the product lifecycle.

“We have an incredible opportunity to reduce the risk of clients who have trusted us with managing their regulatory and quality processes for 40 years by helping them navigate each critical step of their product’s journey,” said Wocko. “Our deep expertise in global regulatory consulting – with the largest global team of regulatory experts and former FDA, MHRA and notified body professionals – differentiates us and serves as the foundation for our expanded services. Our clients have asked us to integrate regulatory, clinical, biocompatibility and market access disciplines to give them efficient, end-to-end support. My goal is to make RQM+ the MedTech partner of choice by removing the challenges of a fragmented service landscape that manufacturers are dealing with today.”

Based in Geneva, Wocko has held commercial leadership roles at both niche and large organizations where she worked closely with clients to develop strategic partnerships that meet their objectives. Her experience spans the MedTech, pharmaceutical and biotech industries, as well as with the contract research organizations (CROs) that serve them.

About RQM+

RQM+ is the leading MedTech service provider with the world’s largest global team of regulatory and quality experts. Building upon 40 years of regulatory expertise, we also provide comprehensive clinical trial, lab and reimbursement services – reducing risk throughout the entire product lifecycle for medical devices, digital therapeutics and diagnostics. With more former FDA, MHRA and notified body regulators than any other firm, the RQM+ team has deep expertise in all clinical specialties. We currently works for 19 of the top 20 medical device manufacturers and seven of the top 10 IVD companies. For more information, visit RQMplus.com.

Contacts

Media: Rob Pepper, +1.301.254.6100, rpepper@rqmplus.com

RQM+



Contacts

Media: Rob Pepper, +1.301.254.6100, rpepper@rqmplus.com

Social Media Profiles
More News From RQM+

RQM+™ Launches Fern.ai™ Smart Authoring Module for MedTech

PITTSBURGH--(BUSINESS WIRE)--RQM+, a leading MedTech service provider, is proud to announce the launch of the Fern.ai Smart Authoring module. The groundbreaking Fern.ai platform now includes Smart Authoring in addition to Systematic Literature Review. Together, these modules are set to transform the landscape of regulatory documentation for MedTech, enhancing compliance, accuracy, and efficiency. As the MedTech sector evolves, regulatory demands grow increasingly complex. Fern.ai's Smart Author...

RQM+™ Appoints Eric Pauls as Chief Customer Officer

PITTSBURGH--(BUSINESS WIRE)--RQM+, a global leader in MedTech services, today announced the appointment of Eric Pauls as chief customer officer, a newly-created senior executive role. With a focus on customer experience and satisfaction, Pauls will steer the company’s global commercialization team, ensuring an alignment between organizational objectives and customer needs. "I'm thrilled to join the RQM+ team and to focus on creating growing value for our customers," said Pauls. "I’m confident t...

RQM+™ Acquires Germany Based CRO Kottmann

PITTSBURGH--(BUSINESS WIRE)--RQM+, a global leader in MedTech services, announces its acquisition of CRO Kottmann, a premier contract research organization (CRO) renowned for its excellent customer service, scientific clinical research and quality in the key market of Germany. This significant move further supports RQM+’s dedication to strategic growth and presence in Europe and emphasizes its dominance in the growing areas of MedTech. The integration of CRO Kottmann enhances RQM+’s existing ge...
Back to Newsroom